Breast implants

Clinical Risk

Volumn 8, Issue 5, 2002, Pages 177-184

  Balen, Paul ^a  

^a Willoughby House   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE; SODIUM CHLORIDE;

BREAST ENDOPROSTHESIS; CONSUMER; FEMALE; HUMAN; HUMAN TISSUE; HYDROGEL; LAW SUIT; LEGAL LIABILITY; LICENSING; MALPRACTICE; MARKETING; PROSTHESIS MATERIAL; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; SILICONE PROSTHESIS; SOYBEAN; SURGICAL RISK; UNITED KINGDOM; UNITED STATES;

EID: 0036733212     PISSN: 13562622     EISSN: None     Source Type: Journal    
DOI: 10.1258/135626202760202745     Document Type: Review

References (29)

1. Department of Health. Booklet, Breast Implants - information for women considering breast implants. London: Department of Health, 2000: p3
2. Kessler DA. The basis of the FDA's decision on breast implants. New Engl J Med 1994; 330: 1748-1749
3. PL/CMO(92)1
4. PL/CMO(93)2
5. Department of Health. Evidence for an Association Between Implantation of Silicones and Connective Tissue Disease MDD Report 92/42. London: Department of Health, 1993
6. Medical Devices Agency. Evaluation of Evidence for an Association Between the Implantation of Silicones and Connective Tissue Disease. Location: Medical Devices Agency, 1994
7. Department of Health. Press release 97/125 4 June 1997; 97/131 12 June 1997
8. Report of the Independent Review Group. Silicone Gel Breast Implants, July 1998. http://www.silicone-review.gov.uk
9. AN1999(01)
10. Medical Devices Agency. Safety warning HN2000(05). Trilucent™ breast implants: recommendation to remove. London: MDA, 2000
11. Medical Devices Agency. Device alert DA2000(07) Breast implants: PIP Hydrogel® DA2000(08) Breast implants: NovaGold™. London: MDA, 2000
12. Department of Health. Booklet: Breast Implants - information for women considering breast implants. London: Department of Health, 2000: p9
13. Harley Medical Group. Letter. (undated, but June 2000)
14. Department of Health. Booklet, Breast Implants - information for women considering breast implants. London: Department of Health, 2000: p7
15. de Camara DL. Rupture and aging of silicone breast implants. Reconstr Surg 1993; 91(5): 828-834
16. Kossovsky et al. Analysis of the surface morichology of recovered silicone mammary prosthesis. Plast Reconstr Surg 1984; 71(6): 795-804
17. Benediktssen and Perbeck. Fluid retention in Bioplasty Misti Gold II breast prosthesis. Scand J Plast Reconstr Hand Surg 2000; 34: 65-70
18. Department of Health. Booklet, Breast Implants - information for women considering breast implants. London: Department of Health, 2000: p8
19. National Academy of Sciences Institute of Medicine. Safety of Silicone Breast Implants. Washington DC: National Academy Press, 1999: p197
20. Medical Devices Agency. Guidance on the Medical Devices Vigilance System for CE Marked breast Implants. London: MDA, 1999
21. http://www.ag.uiuc.edu/.edu~stratsoy/expert/faqs/utilfaq2.html, referring to Surgical Advisory Services of Florida
22. S 2 Consumer Protection Act 1987, implementing European Product Liability Directive (85/374)
23. Novamedical letter to freethcartwright, 20 December 2000
24. PIP to freethcartwright 9 February 2001
25. S3(1) Consumer Protection Act 1987
26. See National Consumer Council Report. PD 451D4195 Unsafe Products, November 1995. 'The 1987 Consumer Protection Act has failed consumers and action needs to be taken to make it work'- NCC press release
27. Burton JA and Others v The National Blood Authority and Another [2001] 3 AII ER 289
28. Unreported City of London County Court April 2000; Cherie Booth QC
29. Article 8, 85/374